CCL19 and hepatocellular carcinoma: In vivo experiments of AAV showed that high expression of CCL19 and CCL21 inhibits the growth of HCC by influencing the infiltration of CD3+ T cells and CD20+ B cells in the subcutaneous xenograft model, while there was a slight significance in the DEN/CCl4-induced tumor models when compared with tumor sizes in two groups.